Literature DB >> 10922298

Specificity in the cAMP/PKA signaling pathway. Differential expression,regulation, and subcellular localization of subunits of PKA.

B S Skalhegg1, K Tasken.   

Abstract

A large number of hormones, neurotransmitters and other signal substances utilize adenosine 3',5' cyclic monophosphate (cAMP) as an intracellular second messenger. Cyclic AMP regulates a number of different cellular processes such as cell growth and differentiation, ion channel conductivity, synaptic release of neurotransmitters, and gene transcription. The principle intracellular target for cAMP in mammalian cells is the cAMP-dependent protein kinase (PKA). The fact that this broad specificity protein kinase mediates a number of discrete physiological responses following cAMP-engagement, has raised the question of how specificity is maintained in the cAMP/PKA system. Here we will describe features of this signaling pathway that may contribute to explain how differential effects of cAMP may be contributed to features of the PKA signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922298     DOI: 10.2741/skalhegg

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  177 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering.

Authors:  J Zhang; Y Ma; S S Taylor; R Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  Designing isoform-specific peptide disruptors of protein kinase A localization.

Authors:  Lora L Burns-Hamuro; Yuliang Ma; Stefan Kammerer; Ulrich Reineke; Chris Self; Charles Cook; Gary L Olson; Charles R Cantor; Andreas Braun; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

4.  Lentiviral vector mediates exogenous gene expression in adult rat DRG following peripheral nerve remote delivery.

Authors:  Ping Yang
Journal:  J Mol Neurosci       Date:  2012-02-09       Impact factor: 3.444

5.  The identification of novel cyclic AMP-dependent protein kinase anchoring proteins using bioinformatic filters and peptide arrays.

Authors:  William A McLaughlin; Tingjun Hou; Susan S Taylor; Wei Wang
Journal:  Protein Eng Des Sel       Date:  2010-11-29       Impact factor: 1.650

6.  Distinct PKA regulatory subunits mediate PGE2 inhibition of TGFβ-1-stimulated collagen I translation and myofibroblast differentiation.

Authors:  Scott H Wettlaufer; L Raghu Penke; Katsuhide Okunishi; Marc Peters-Golden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-20       Impact factor: 5.464

7.  Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia.

Authors:  Dong-Mei Wu; Xin Wen; Xin-Rui Han; Shan Wang; Yong-Jian Wang; Min Shen; Shao-Hua Fan; Zi-Feng Zhang; Qun Shan; Meng-Qiu Li; Bin Hu; Gui-Quan Chen; Jun Lu; Yuan-Lin Zheng
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

8.  Rolipram Attenuates Early Brain Injury Following Experimental Subarachnoid Hemorrhage in Rats: Possibly via Regulating the SIRT1/NF-κB Pathway.

Authors:  Yucong Peng; Jianxiang Jin; Linfeng Fan; Hangzhe Xu; Pingyou He; Jianru Li; Ting Chen; Wu Ruan; Gao Chen
Journal:  Neurochem Res       Date:  2018-02-03       Impact factor: 3.996

9.  Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism.

Authors:  Stefan Kammerer; Lora L Burns-Hamuro; Yuliang Ma; Sara C Hamon; Jaume M Canaves; Michael M Shi; Matthew R Nelson; Charles F Sing; Charles R Cantor; Susan S Taylor; Andreas Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

10.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.